Abstract
17 beta-Estradiol (E2) induces cathepsin D mRNA levels and intracellular levels of immunoreactive protein in MCF-7 human breast cancer cells. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alone does not affect cathepsin D gene expression in this cell line; however, in cells cotreated with TCDD and E2, TCDD inhibited E2-induced cathepsin D mRNA levels, the rate of gene transcription, and levels of immunoreactive protein. The inhibitory responses were observed within 30 to 120 min after the cells were treated with TCDD. TCDD also inhibited E2-induced secreted alkaline phosphatase activity in aryl hydrocarbon (Ah)-responsive MCF-7 and wild-type mouse Hepa 1c1c7 cells cotransfected with the human estrogen receptor (hER) and the pBC12/S1/pac plasmid, which contains the 5' promoter region (-296/+57) of the cathepsin D gene and an alkaline phosphatase reporter gene. The E2-responsive ER/Sp1 sequence (-199 to -165) in the cathepsin D 5' region contains an imperfect GTGCGTG (-175/-181) xenobiotic responsive element (XRE); the role of this sequence in Ah responsiveness was investigated in gel electrophoretic mobility shift assays and with plasmid constructs containing a wild-type ER/Sp1 oligonucleotide or a mutant ER/Sp1-"XRE" oligonucleotide containing two C-->A mutations in the XRE sequence (antisense strand). In plasmid constructs which contained a chloramphenicol acetyltransferase reporter gene and the wild-type ER/Sp1 promoter sequence, E2-induced chloramphenicol acetyltransferase activity and mRNA levels were inhibited by TCDD whereas no inhibition was observed with the mutant ER/Sp1-"XRE" plasmids. Electrophoretic mobility shift assays showed that the nuclear or transformed cytosolic Ah receptor complex blocked formation of the ER-Sp1 complex with the wild-type but not the ER/Sp1 mutant oligonucleotide. Moreover, incubation of the wild-type bromodeoxyuridine-substituted ER/Sp1 oligonucleotide with the nuclear Ah receptor complex gave a specifically bound cross-linked 200-kDa band. These data demonstrate that Ah receptor-mediated inhibition of E2-induced cathepsin D gene expression is due to disruption of the ER-Sp1 complex by targeted interaction with an overlapping XRE.
Full Text
The Full Text of this article is available as a PDF (459.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Asman D. C., Takimoto K., Pitot H. C., Dunn T. J., Lindahl R. Organization and characterization of the rat class 3 aldehyde dehydrogenase gene. J Biol Chem. 1993 Jun 15;268(17):12530–12536. [PubMed] [Google Scholar]
- Astroff B., Eldridge B., Safe S. Inhibition of the 17 beta-estradiol-induced and constitutive expression of the cellular protooncogene c-fos by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the female rat uterus. Toxicol Lett. 1991 May;56(3):305–315. doi: 10.1016/0378-4274(91)90159-4. [DOI] [PubMed] [Google Scholar]
- Astroff B., Rowlands C., Dickerson R., Safe S. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibition of 17 beta-estradiol-induced increases in rat uterine epidermal growth factor receptor binding activity and gene expression. Mol Cell Endocrinol. 1990 Sep 10;72(3):247–252. doi: 10.1016/0303-7207(90)90149-3. [DOI] [PubMed] [Google Scholar]
- Augereau P., Miralles F., Cavaillès V., Gaudelet C., Parker M., Rochefort H. Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol Endocrinol. 1994 Jun;8(6):693–703. doi: 10.1210/mend.8.6.7935485. [DOI] [PubMed] [Google Scholar]
- Berger J., Hauber J., Hauber R., Geiger R., Cullen B. R. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene. 1988 Jun 15;66(1):1–10. doi: 10.1016/0378-1119(88)90219-3. [DOI] [PubMed] [Google Scholar]
- Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
- Burbach K. M., Poland A., Bradfield C. A. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8185–8189. doi: 10.1073/pnas.89.17.8185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cavailles V., Augereau P., Garcia M., Rochefort H. Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells. Nucleic Acids Res. 1988 Mar 25;16(5):1903–1919. doi: 10.1093/nar/16.5.1903. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cavailles V., Augereau P., Rochefort H. Cathepsin D gene of human MCF7 cells contains estrogen-responsive sequences in its 5' proximal flanking region. Biochem Biophys Res Commun. 1991 Jan 31;174(2):816–824. doi: 10.1016/0006-291x(91)91491-t. [DOI] [PubMed] [Google Scholar]
- Cavailles V., Garcia M., Rochefort H. Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. Mol Endocrinol. 1989 Mar;3(3):552–558. doi: 10.1210/mend-3-3-552. [DOI] [PubMed] [Google Scholar]
- Cavaillès V., Augereau P., Rochefort H. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):203–207. doi: 10.1073/pnas.90.1.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
- Cuthill S., Wilhelmsson A., Poellinger L. Role of the ligand in intracellular receptor function: receptor affinity determines activation in vitro of the latent dioxin receptor to a DNA-binding form. Mol Cell Biol. 1991 Jan;11(1):401–411. doi: 10.1128/mcb.11.1.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dauvois S., Danielian P. S., White R., Parker M. G. Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci U S A. 1992 May 1;89(9):4037–4041. doi: 10.1073/pnas.89.9.4037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Denison M. S., Fisher J. M., Whitlock J. P., Jr Inducible, receptor-dependent protein-DNA interactions at a dioxin-responsive transcriptional enhancer. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2528–2532. doi: 10.1073/pnas.85.8.2528. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Denison M. S., Fisher J. M., Whitlock J. P., Jr The DNA recognition site for the dioxin-Ah receptor complex. Nucleotide sequence and functional analysis. J Biol Chem. 1988 Nov 25;263(33):17221–17224. [PubMed] [Google Scholar]
- Dubik D., Shiu R. P. Mechanism of estrogen activation of c-myc oncogene expression. Oncogene. 1992 Aug;7(8):1587–1594. [PubMed] [Google Scholar]
- Elferink C. J., Gasiewicz T. A., Whitlock J. P., Jr Protein-DNA interactions at a dioxin-responsive enhancer. Evidence that the transformed Ah receptor is heteromeric. J Biol Chem. 1990 Nov 25;265(33):20708–20712. [PubMed] [Google Scholar]
- Gaido K. W., Maness S. C., Leonard L. S., Greenlee W. F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent regulation of transforming growth factors-alpha and -beta 2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control. J Biol Chem. 1992 Dec 5;267(34):24591–24595. [PubMed] [Google Scholar]
- Gallo M. A., Hesse E. J., Macdonald G. J., Umbreit T. H. Interactive effects of estradiol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic cytochrome P-450 and mouse uterus. Toxicol Lett. 1986 Jul-Aug;32(1-2):123–132. doi: 10.1016/0378-4274(86)90058-5. [DOI] [PubMed] [Google Scholar]
- Gierthy J. F., Bennett J. A., Bradley L. M., Cutler D. S. Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res. 1993 Jul 1;53(13):3149–3153. [PubMed] [Google Scholar]
- Gierthy J. F., Lincoln D. W., 2nd Inhibition of postconfluent focus production in cultures of MCF-7 human breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Breast Cancer Res Treat. 1988 Oct;12(2):227–233. doi: 10.1007/BF01805943. [DOI] [PubMed] [Google Scholar]
- Gierthy J. F., Lincoln D. W., 2nd, Roth K. E., Bowser S. S., Bennett J. A., Bradley L., Dickerman H. W. Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells. J Cell Biochem. 1991 Feb;45(2):177–187. doi: 10.1002/jcb.240450209. [DOI] [PubMed] [Google Scholar]
- Gierthy J. F., Lincoln D. W., Gillespie M. B., Seeger J. I., Martinez H. L., Dickerman H. W., Kumar S. A. Suppression of estrogen-regulated extracellular tissue plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res. 1987 Dec 1;47(23):6198–6203. [PubMed] [Google Scholar]
- Gonzalez F. J., Nebert D. W. Autoregulation plus upstream positive and negative control regions associated with transcriptional activation of the mouse P1(450) gene. Nucleic Acids Res. 1985 Oct 25;13(20):7269–7288. doi: 10.1093/nar/13.20.7269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982 Sep;2(9):1044–1051. doi: 10.1128/mcb.2.9.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hankinson O. Research on the aryl hydrocarbon (dioxin) receptor is primed to take off. Arch Biochem Biophys. 1993 Jan;300(1):1–5. doi: 10.1006/abbi.1993.1001. [DOI] [PubMed] [Google Scholar]
- Harper N., Wang X., Liu H., Safe S. Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists. Mol Cell Endocrinol. 1994 Aug;104(1):47–55. doi: 10.1016/0303-7207(94)90050-7. [DOI] [PubMed] [Google Scholar]
- Hoffman E. C., Reyes H., Chu F. F., Sander F., Conley L. H., Brooks B. A., Hankinson O. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science. 1991 May 17;252(5008):954–958. doi: 10.1126/science.1852076. [DOI] [PubMed] [Google Scholar]
- Holcomb M., Safe S. Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Lett. 1994 Jul 15;82(1):43–47. doi: 10.1016/0304-3835(94)90144-9. [DOI] [PubMed] [Google Scholar]
- Hudson L. G., Toscano W. A., Jr, Greenlee W. F. Regulation of epidermal growth factor binding in a human keratinocyte cell line by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol. 1985 Feb;77(2):251–259. doi: 10.1016/0041-008x(85)90324-2. [DOI] [PubMed] [Google Scholar]
- Israel D. I., Whitlock J. P., Jr Regulation of cytochrome P1-450 gene transcription by 2,3,7, 8-tetrachlorodibenzo-p-dioxin in wild type and variant mouse hepatoma cells. J Biol Chem. 1984 May 10;259(9):5400–5402. [PubMed] [Google Scholar]
- Jaiswal A. K. Human NAD(P)H:quinone oxidoreductase2. Gene structure, activity, and tissue-specific expression. J Biol Chem. 1994 May 20;269(20):14502–14508. [PubMed] [Google Scholar]
- Klein-Hitpass L., Schorpp M., Wagner U., Ryffel G. U. An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell. 1986 Sep 26;46(7):1053–1061. doi: 10.1016/0092-8674(86)90705-1. [DOI] [PubMed] [Google Scholar]
- Kociba R. J., Keyes D. G., Beyer J. E., Carreon R. M., Wade C. E., Dittenber D. A., Kalnins R. P., Frauson L. E., Park C. N., Barnard S. D. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol. 1978 Nov;46(2):279–303. doi: 10.1016/0041-008x(78)90075-3. [DOI] [PubMed] [Google Scholar]
- Krishnan V., Narasimhan T., Safe S. Development of gel staining techniques for detecting the secretion of procathepsin D (52-kDa protein) in MCF-7 human breast cancer cells. Anal Biochem. 1992 Jul;204(1):137–142. doi: 10.1016/0003-2697(92)90152-w. [DOI] [PubMed] [Google Scholar]
- Krishnan V., Safe S. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), and dibenzofurans (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: quantitative structure-activity relationships. Toxicol Appl Pharmacol. 1993 May;120(1):55–61. doi: 10.1006/taap.1993.1086. [DOI] [PubMed] [Google Scholar]
- Krishnan V., Wang X., Safe S. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J Biol Chem. 1994 Jun 3;269(22):15912–15917. [PubMed] [Google Scholar]
- Kärenlampi S. O., Eisen H. J., Hankinson O., Nebert D. W. Effects of cytochrome P1-450 inducers on the cell-surface receptors for epidermal growth factor, phorbol 12,13-dibutyrate, or insulin of cultured mouse hepatoma cells. J Biol Chem. 1983 Sep 10;258(17):10378–10383. [PubMed] [Google Scholar]
- Landers J. P., Bunce N. J. The Ah receptor and the mechanism of dioxin toxicity. Biochem J. 1991 Jun 1;276(Pt 2):273–287. doi: 10.1042/bj2760273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Madhukar B. V., Brewster D. W., Matsumura F. Effects of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse, and hamster. Proc Natl Acad Sci U S A. 1984 Dec;81(23):7407–7411. doi: 10.1073/pnas.81.23.7407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Manchester D. K., Gordon S. K., Golas C. L., Roberts E. A., Okey A. B. Ah receptor in human placenta: stabilization by molybdate and characterization of binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, and benzo(a)pyrene. Cancer Res. 1987 Sep 15;47(18):4861–4868. [PubMed] [Google Scholar]
- Marzluff W. F., Jr Transcription of RNA in isolated nuclei. Methods Cell Biol. 1978;19:317–332. doi: 10.1016/s0091-679x(08)60032-1. [DOI] [PubMed] [Google Scholar]
- May F. E., Smith D. J., Westley B. R. The human cathepsin D-encoding gene is transcribed from an estrogen-regulated and a constitutive start point. Gene. 1993 Dec 8;134(2):277–282. doi: 10.1016/0378-1119(93)90107-e. [DOI] [PubMed] [Google Scholar]
- May F. E., Westley B. R. Effects of tamoxifen and 4-hydroxytamoxifen on the pNR-1 and pNR-2 estrogen-regulated RNAs in human breast cancer cells. J Biol Chem. 1987 Nov 25;262(33):15894–15899. [PubMed] [Google Scholar]
- McGuire J., Whitelaw M. L., Pongratz I., Gustafsson J. A., Poellinger L. A cellular factor stimulates ligand-dependent release of hsp90 from the basic helix-loop-helix dioxin receptor. Mol Cell Biol. 1994 Apr;14(4):2438–2446. doi: 10.1128/mcb.14.4.2438. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Merchant M., Krishnan V., Safe S. Mechanism of action of alpha-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells. Toxicol Appl Pharmacol. 1993 Jun;120(2):179–185. doi: 10.1006/taap.1993.1101. [DOI] [PubMed] [Google Scholar]
- Miller A. G., Israel D., Whitlock J. P., Jr Biochemical and genetic analysis of variant mouse hepatoma cells defective in the induction of benzo(a)pyrene-metabolizing enzyme activity. J Biol Chem. 1983 Mar 25;258(6):3523–3527. [PubMed] [Google Scholar]
- Moore M., Wang X., Lu Y. F., Wormke M., Craig A., Gerlach J. H., Burghardt R., Barhoumi R., Safe S. Benzo[a]pyrene-resistant MCF-7 human breast cancer cells. A unique aryl hydrocarbon-nonresponsive clone. J Biol Chem. 1994 Apr 22;269(16):11751–11759. [PubMed] [Google Scholar]
- Morisset M., Capony F., Rochefort H. Processing and estrogen regulation of the 52-kilodalton protein inside MCF7 breast cancer cells. Endocrinology. 1986 Dec;119(6):2773–2782. doi: 10.1210/endo-119-6-2773. [DOI] [PubMed] [Google Scholar]
- Nebert D. W., Petersen D. D., Puga A. Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion products and dioxin. Pharmacogenetics. 1991 Nov;1(2):68–78. doi: 10.1097/00008571-199111000-00003. [DOI] [PubMed] [Google Scholar]
- Okey A. B., Riddick D. S., Harper P. A. The Ah receptor: mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol Lett. 1994 Jan;70(1):1–22. doi: 10.1016/0378-4274(94)90139-2. [DOI] [PubMed] [Google Scholar]
- Perdew G. H. Association of the Ah receptor with the 90-kDa heat shock protein. J Biol Chem. 1988 Sep 25;263(27):13802–13805. [PubMed] [Google Scholar]
- Pimental R. A., Liang B., Yee G. K., Wilhelmsson A., Poellinger L., Paulson K. E. Dioxin receptor and C/EBP regulate the function of the glutathione S-transferase Ya gene xenobiotic response element. Mol Cell Biol. 1993 Jul;13(7):4365–4373. doi: 10.1128/mcb.13.7.4365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piskorska-Pliszczynska J., Keys B., Safe S., Newman M. S. The cytosolic receptor binding affinities and AHH induction potencies of 29 polynuclear aromatic hydrocarbons. Toxicol Lett. 1986 Nov;34(1):67–74. doi: 10.1016/0378-4274(86)90146-3. [DOI] [PubMed] [Google Scholar]
- Poland A., Glover E., Kende A. S. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J Biol Chem. 1976 Aug 25;251(16):4936–4946. [PubMed] [Google Scholar]
- Poland A., Knutson J. C. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol. 1982;22:517–554. doi: 10.1146/annurev.pa.22.040182.002505. [DOI] [PubMed] [Google Scholar]
- Pongratz I., Mason G. G., Poellinger L. Dual roles of the 90-kDa heat shock protein hsp90 in modulating functional activities of the dioxin receptor. Evidence that the dioxin receptor functionally belongs to a subclass of nuclear receptors which require hsp90 both for ligand binding activity and repression of intrinsic DNA binding activity. J Biol Chem. 1992 Jul 5;267(19):13728–13734. [PubMed] [Google Scholar]
- Probst M. R., Reisz-Porszasz S., Agbunag R. V., Ong M. S., Hankinson O. Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action. Mol Pharmacol. 1993 Sep;44(3):511–518. [PubMed] [Google Scholar]
- Quattrochi L. C., Tukey R. H. The human cytochrome Cyp1A2 gene contains regulatory elements responsive to 3-methylcholanthrene. Mol Pharmacol. 1989 Jul;36(1):66–71. [PubMed] [Google Scholar]
- Redecker B., Heckendorf B., Grosch H. W., Mersmann G., Hasilik A. Molecular organization of the human cathepsin D gene. DNA Cell Biol. 1991 Jul-Aug;10(6):423–431. doi: 10.1089/dna.1991.10.423. [DOI] [PubMed] [Google Scholar]
- Rushmore T. H., King R. G., Paulson K. E., Pickett C. B. Regulation of glutathione S-transferase Ya subunit gene expression: identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds. Proc Natl Acad Sci U S A. 1990 May;87(10):3826–3830. doi: 10.1073/pnas.87.10.3826. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Safe S., Astroff B., Harris M., Zacharewski T., Dickerson R., Romkes M., Biegel L. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antioestrogens: characterization and mechanism of action. Pharmacol Toxicol. 1991 Dec;69(6):400–409. doi: 10.1111/j.1600-0773.1991.tb01321.x. [DOI] [PubMed] [Google Scholar]
- Safe S., Bandiera S., Sawyer T., Zmudzka B., Mason G., Romkes M., Denomme M. A., Sparling J., Okey A. B., Fujita T. Effects of structure on binding to the 2,3,7,8-TCDD receptor protein and AHH induction--halogenated biphenyls. Environ Health Perspect. 1985 Sep;61:21–33. doi: 10.1289/ehp.856121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Savouret J. F., Bailly A., Misrahi M., Rauch C., Redeuilh G., Chauchereau A., Milgrom E. Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene. EMBO J. 1991 Jul;10(7):1875–1883. doi: 10.1002/j.1460-2075.1991.tb07713.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sogawa K., Fujisawa-Sehara A., Yamane M., Fujii-Kuriyama Y. Location of regulatory elements responsible for drug induction in the rat cytochrome P-450c gene. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8044–8048. doi: 10.1073/pnas.83.21.8044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stahl B. U., Beer D. G., Weber L. W., Rozman K. Reduction of hepatic phosphoenolpyruvate carboxykinase (PEPCK) activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is due to decreased mRNA levels. Toxicology. 1993 Mar 30;79(1):81–95. doi: 10.1016/0300-483x(93)90207-9. [DOI] [PubMed] [Google Scholar]
- Swanson H. I., Bradfield C. A. The AH-receptor: genetics, structure and function. Pharmacogenetics. 1993 Oct;3(5):213–230. doi: 10.1097/00008571-199310000-00001. [DOI] [PubMed] [Google Scholar]
- Tandon A. K., Clark G. M., Chamness G. C., Chirgwin J. M., McGuire W. L. Cathepsin D and prognosis in breast cancer. N Engl J Med. 1990 Feb 1;322(5):297–302. doi: 10.1056/NEJM199002013220504. [DOI] [PubMed] [Google Scholar]
- Thorpe S. M., Rochefort H., Garcia M., Freiss G., Christensen I. J., Khalaf S., Paolucci F., Pau B., Rasmussen B. B., Rose C. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res. 1989 Nov 1;49(21):6008–6014. [PubMed] [Google Scholar]
- Wakeling A. E. Regulatory mechanisms in breast cancer. Steroidal pure antiestrogens. Cancer Treat Res. 1991;53:239–257. [PubMed] [Google Scholar]
- Wang X., Narasimhan T. R., Morrison V., Safe S. In situ and in vitro photoaffinity labeling of the nuclear aryl hydrocarbon receptor from transformed rodent and human cell lines. Arch Biochem Biophys. 1991 May 15;287(1):186–194. doi: 10.1016/0003-9861(91)90405-8. [DOI] [PubMed] [Google Scholar]
- Westley B. R., Hölzel F., May F. E. Effects of oestrogen and the antioestrogens, tamoxifen and LY117018, on four oestrogen-regulated RNAs in the EFM-19 breast cancer cell line. J Steroid Biochem. 1989 Mar;32(3):365–372. doi: 10.1016/0022-4731(89)90208-2. [DOI] [PubMed] [Google Scholar]
- Westley B. R., May F. E. Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells. Nucleic Acids Res. 1987 May 11;15(9):3773–3786. doi: 10.1093/nar/15.9.3773. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Westley B., May F. E., Brown A. M., Krust A., Chambon P., Lippman M. E., Rochefort H. Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines. J Biol Chem. 1984 Aug 25;259(16):10030–10035. [PubMed] [Google Scholar]
- Whitlock J. P., Jr, Denison M. S., Durrin L. K., Fisher J. M., Galeazzi D. R., Jones P. B. Regulation of cytochrome P1-450 gene expression in mouse hepatoma cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Drug Metab Rev. 1989;20(2-4):839–846. doi: 10.3109/03602538909103583. [DOI] [PubMed] [Google Scholar]
- Whitlock J. P., Jr Mechanistic aspects of dioxin action. Chem Res Toxicol. 1993 Nov-Dec;6(6):754–763. doi: 10.1021/tx00036a003. [DOI] [PubMed] [Google Scholar]
- Wu-Peng X. S., Pugliese T. E., Dickerman H. W., Pentecost B. T. Delineation of sites mediating estrogen regulation of the rat creatine kinase B gene. Mol Endocrinol. 1992 Feb;6(2):231–240. doi: 10.1210/mend.6.2.1569966. [DOI] [PubMed] [Google Scholar]
- Zacharewski T. R., Bondy K. L., McDonell P., Wu Z. F. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced pS2 expression. Cancer Res. 1994 May 15;54(10):2707–2713. [PubMed] [Google Scholar]